# Akoya Biosciences

Akoya's PhenoCycler-Fusion is the spatial-proteomics leader, detecting 100-plus protein biomarkers per section at 0.25 µm/pixel with cyclic immunofluorescence plus in-situ-hybridisation RNA modules;…

Source: https://en.bioecon.ru/companies/akoya-biosciences/
Updated: 2026-08-15

- Country: United States

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Funding | Raised about $262.1 million total in gross disclosed equity financing, including private rounds, its 2021 IPO, and a 2023 follow-on offering (2023-06-12) | https://biobase.whitefordresearch.com/companies/akoya-biosciences |
| Capacity | 5–100 tissue sections per week for the PhenoCycler-Fusion platform (2026-03-06) | https://www.instrumenthive.com/products/akoya-biosciences-phenocycler-fusion-single-cell-situ-spatial-omics-analysis-platform/ |
| Certification | ABS laboratory in Marlborough, Massachusetts is CLIA certified (2024-12-31) | https://www.sec.gov/Archives/edgar/data/1711933/000155837025003124/akya-20241231x10k.htm |
| Regulatory approval | PhenoCycler-Fusion complies with FDA 21 CFR Part 11 requirements for electronic records and signatures when used with validated software (2026-03-06) | https://www.instrumenthive.com/products/akoya-biosciences-phenocycler-fusion-single-cell-situ-spatial-omics-analysis-platform/ |
| Production site | Manufacturing facility in Marlborough, Massachusetts (2024-12-31) | https://investors.akoyabio.com/news-releases/news-release-details/akoya-biosciences-opens-operations-and-manufacturing-center, https://www.sec.gov/Archives/edgar/data/1711933/000155837025003124/akya-20241231x10k.htm |
| Headcount | 205 employees (2024-12-31) | https://www.sec.gov/Archives/edgar/data/1711933/000155837025003124/akya-20241231x10k.htm |
| Revenue | $81.7 million total revenue for the year 2024 (2024-12-31) | https://www.sec.gov/Archives/edgar/data/1711933/000155837025003124/akya-20241231x10k.htm |

Independent sources: biobase.whitefordresearch.com, instrumenthive.com, investors.akoyabio.com, sec.gov

## Technologies

- [Spatial transcriptomics & spatial multi-omics](https://en.bioecon.ru/technology/spatial-transcriptomics-spatial-multi-omics/)
